Notícias e Atividades da BlueSphere Bio
Executivos
Veja o organograma con seus 11 executivos principais
Biografias mais buscadas da BlueSphere Bio
- Keir Loiacono, Chief Executive Officer and Director
- Jeanne Cunicelli, Board Member
- Alan Korman, Board Member
Criar um alerta
para seguir os movimentos de executivos da BlueSphere Bio.
Biotecnologia
BlueSphere Bio possui 2.350 concorrentes concorrentes Eurofins (Luxemburgo), Lonza (Suíça) e Johnson & Johnson Innovative Medicine DIA (Estados Unidos).
Popular M&A news in Biotecnologia
- Transcarent and Accolade have merged (publicado em 9 de abril de 2025)..
- Kashiv BioSciences acaba de anunciar uma arrecadação de fundos de 150 milhões de dólares. (publicado em 7 de abril de 2025).
- Atsena Therapeutics acaba de anunciar uma arrecadação de fundos de 150 milhões de dólares. (publicado em 4 de abril de 2025).
Outros contatos sugeridos na indústria do Biotecnologia
Notícias
Últimos comunicados de imprensa de BlueSphere Bio
- BlueSphere Bio To Partner with NMDP BioTherapies℠ for the Company’s First-In-Human TCR-based Product Candidate in Combination with Allogeneic Hematopoietic Cell Transplantation Trial | BlueSphere Bio
- BlueSphere Bio Accepted as Member of Johnson & Johnson Innovation-JLABS | BlueSphere Bio
- BlueSphere Bio To Partner with NMDP BioTherapies℠ for the Company’s First-In-Human TCR-based Product Candidate in Combination with Allogeneic Hematopoietic Cell Transplantation Trial
- BlueSphere Bio Announces IND Clearance of its First in Human Candidate and New Cell Therapy Portfolio for High-Risk Leukemia Patients | BlueSphere Bio
- BlueSphere Bio Establishes Strategic Collaboration with the National Cancer Institute to Advance Treatments for Rare Respiratory Disease | BlueSphere Bio
- BlueSphere Bio to Present Corporate Update and Participate in a Panel Discussion at the 2024 BIO International Convention | BlueSphere Bio
- BlueSphere Bio to Present at the Next Generation CAR & T Cell Therapies Conference | BlueSphere Bio
- BlueSphere Bio to Present at the 25th Annual BIO CEO & Investor Conference | BlueSphere Bio
- BlueSphere Bio Appoints Erkut Bahceci, M.D., as Chief Medical Officer | BlueSphere Bio
- BlueSphere Bio Presents Data Demonstrating the Potential of Lead Product Candidate at 37th Society for Immunotherapy of Cancer (SITC) Annual Meeting | BlueSphere Bio
- View more press releases Close
Redes sociais sobre BlueSphere Bio
- BlueSphere Bio na Wikipedia, Google News e Yahoo Finance
- BlueSphere Bio na LinkedIn, Twitter e YouTube
